Scaling care for millions. Instantly.
The first EU-MDR Class IIb certified autonomous AI detecting serious eye diseases in seconds — Approved for use by any healthcare professional, not limited to ophthalmology expertise
One retinal image. Multiple health insights.
Aireen's Diabetic Retinopathy and Age-related Macular Degeneration modules are EU-MDR Class IIb certified and available on the market today. Cardiovascular Disease Risk and neurodegenerative indications from the same single, non-invasive 45° fundus scan are currently under development.
Aireen's AI analyzes one non-invasive retinal image and surfaces three independent clinical insights in seconds — without specialist review.
- Diabetic Retinopathy — microaneurysms, hemorrhages, hard exudates, nerve fiber layer abnormalities and other signs of DR. On market
- Age-related Macular Degeneration — drusen, pigment abnormalities and other early signs of AMD. On market
- Cardiovascular Disease Risk — arteriolar narrowing, venular widening, AV nicking. In development
Diabetic Retinopathy (DR)
AI detects microaneurysms, hemorrhages, hard exudates and other early signs of DR.
- Microaneurysms
- Hemorrhages
- Hard exudates
- Nerve fiber layer abnormalities
Age-related Macular Degeneration (AMD)
AI identifies drusen, pigment changes and other early signs of AMD.
- Drusen
- Pigment abnormalities
Cardiovascular Disease (CVD) Risk
AI analyzes vascular signs linked to increased CVD risk.
- Arteriolar narrowing
- Venular widening
- AV nicking
One certified platform. Five tailored programs.
Select your segment to see the operating model, clinical evidence, and commercial impact built for your team.
Filter out the healthy. Reclaim your primary focus.
Aireen acts as an autonomous diagnostic triage filter. By shifting routine, high-volume diabetic retinopathy (DR) and age-related macular degeneration (AMD) screenings to an EU-MDR Class IIb certified AI, eye clinics eliminate administrative bottlenecks, reduce waiting room saturation, and focus human expertise strictly on complex specialized clinical care .
vs. Expert Panel Baseline
Multi-center clinical trial (n=1,274 diabetic patients) comparing Aireen DR with retinal specialists and general ophthalmologists against a gold-standard expert panel. According to the EU-MDR regulatory process, Risk class IIb (CE 2265).
Capture to certified report
- 1Capture standard 45° fundus imageSingle/multiple image(s) per eye, compatible with most commonly used fundus camera.
- 2Instant AI quality check & disease analysisEncrypted upload, AI grading across DR severity levels and AMD analysis, ISO 27001:2023 audit trail.
- 3Clinical report in secondsClear result without the need for ophthalmologist interpretation.
How it works
Step 1Retina Scan Capture & Cloud Upload
Handheld or tabletop fundus camera scan.
Step 2Data Validation & AI Analysis
Aireen performs instant quality check and feedback to operator.
- PDFReportICDRR0R1R2R3R4Step 3
Report Provided
Report indicating presence or absence of symptoms.
Hardware agnostic
Aireen is hardware independent — the software can work with any validated fundus image from various camera manufacturers meeting the defined technical criteria.
Evidence enterprise medicine can stand behind.
Several multi-center clinical trials have been performed for DR and AMD indications.
Legally valid autonomous medical diagnostic capabilities across the EU.
Full international enterprise information security framework compliance.
Certified quality management system for design, development, configuration, sale, installation and service of software devices.
See certified retinal AI in your environment.
Tell us who you are and we'll route you to the right specialist — clinical, commercial or integration.